Tauriga Sciences Inc. Reports Meaningful Progress With Respect to its Ongoing Pharmaceutical Development Efforts

The Company has finalized the formulation blueprint for its proposed Pharmaceutical Grade Version of Tauri-Gum NEW YORK, NY, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as